Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence.
about
Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients.Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's DiseaseSuccessful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease: A Case-Based ReviewBiologic treatments for adult-onset Still's disease.Treatment advances in systemic juvenile idiopathic arthritis.IL-6 biology: implications for clinical targeting in rheumatic disease.IL-6 blockade in chronic inflammatory diseases.Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.Treatment of adult-onset still's disease: up to date.Tocilizumab for uncontrollable systemic inflammatory response syndrome complicating adult-onset Still disease: Case report and review of literature.Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?Severe hyperferritinemia--a clue for severe hepatitis in a patient with adult-onset Still's disease.Nationwide epidemiological survey of 169 patients with adult Still's disease in Japan.Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still's Disease.Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.Biological therapy of traditional therapy-resistant adult-onset Still's disease: an evidence-based review.
P2860
Q33414045-3F0138C4-9EF0-4B2B-8F61-547DABECAC70Q34399037-372AE232-89E6-4E22-A371-5DA27E23E712Q37263772-BA6A0EC1-6DBF-47AB-881C-482289D41BDDQ38122317-2C814114-18E6-4EC2-BDD2-0462EF41C92AQ38207061-C5ECF396-C07B-47D0-85BB-8530861EE19CQ38241232-236A468B-80B5-4948-A647-0E7256604013Q38261783-23F98048-7233-46E8-B65C-B94533D15083Q38329024-66C000A3-C423-49EB-94F1-554C79C75098Q38679486-67E63BD3-7449-4309-9269-6CBD35B89751Q39445471-59845146-7D0B-4F78-A1C7-E960B80C435AQ39748097-25E42964-D2CD-48AD-952A-9CBB0DE4ED8EQ40116554-1CB5B0EB-AB4A-4101-B94F-CE304E41BF47Q40182074-D24ADC9D-DA00-4FBA-8185-1FF65C07BB22Q40183555-F549B048-3130-490B-B5DD-F25AC2B95607Q40218234-75BB2EDC-7314-4E2D-BAA8-6088E69D6DEBQ40235629-278D3C1F-F025-41F7-AF86-8A4D19FBFB98Q42677427-4728EBEA-0A84-443E-B8FF-4FFA6FCE5CF4Q48266470-62740F06-D1BA-4D34-98D2-100CA9E5EBC0Q49251571-91F0BA33-36B5-4466-92C4-57B1B55BB4A2
P2860
Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tocilizumab in the treatment o ...... se: current clinical evidence.
@en
type
label
Tocilizumab in the treatment o ...... se: current clinical evidence.
@en
prefLabel
Tocilizumab in the treatment o ...... se: current clinical evidence.
@en
P2093
P2860
P1476
Tocilizumab in the treatment o ...... se: current clinical evidence.
@en
P2093
Amélie Nicolle
Christophe Auzary
Hubert de Boysson
Jérome Février
Loïk Geffray
P2860
P304
P356
10.1007/S10067-012-2105-2
P577
2012-10-30T00:00:00Z